Home / Erythromycin / Canada
CA ATC S01AA17 · updated 2 Nov 2026
Erythromycin shortage in Canada
Is there an Erythromycin shortage in Canada?
Yes. As of 2 Nov 2026, 3 Erythromycin products are reported short in Canada, the first since 29 Sep 2017. The company estimate for the return is 14 Dec 2026. Main reason: increased demand.
Also short in Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ODAN-ERYTHROMYCIN (50 x 1g) | ODAN LABORATORIES LTD | 29 Sep 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ODAN-ERYTHROMYCIN (3.5 g) | ODAN LABORATORIES LTD | 8 Jun 2018 | not given | Increased demand Demand increase for the drug |
| CA | ERYTHROMYCIN OPHTHALMIC OINTMENT USP (50 x 1g) | STERI-MED PHARMA INC. | 1 Oct 2026 | 14 Dec 2026 | Increased demand Demand increase for the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.